Thrasos Therapeutics, a Canada-based drug developer focused on acute kidney injuries, has raised $35m from a consortium led by drugs company GlaxoSmithKline’s (GSK) corporate venturing unit. SR One’s commitment came from its GSK Canada Life Sciences Innovation Fund set up at the end of last year. Jens Eckstein, president of SR One, said: “Thrasos’ lead… Continue reading GSK backs Thrasos Therapeutics
Month: October 2012
BrightSource shines with $80m
BrightSource Energy, a US-based solar thermal company backed by numerous corporate venturing units including France-based power equipment company Alstom’s, has raised $80m following its failure to float in April. The series F round takes BrightSource’s total equity raised to more than $615m, excluding more than $1.6bn in US governmnet and other loans to help build… Continue reading BrightSource shines with $80m
Merck secures AiCuris’s portfolio for $142m
Bayer spin-off AiCuris has entered into a potential $429m deal with Merck.
Celgene treats PharmAria
Celgene will provided seed-stage funding as well as help the company raise its series A round and will also have the option to acquire PharmAria.
Mainport powers up Ampyx
Mainport, which invests on behalf of fund investors like KLM, Rabobank, Schiphol and Delft University of Technology and the Worldwide Fund for Nature (WWF), backs the airborne wind energy company.
Ancestry endowed with $1.6bn from Permira
Permira snaps up Ancestry, which raised venture funding from AOL and Compaq, in a take-private deal.
Intel, Runa aggregate $4m for Eruditor
Intel Capital leads $4m A round for Russia-based service marketplace backed by Runa Capital, a Moscow based international venture fund.
Google shares $6m for TopFloor
Google Ventures has participated in a $6m Series A for social e-commerce website TopFloor.
Newscred acquires Daylife
News syndication service Newscred has acquired news aggregation Daylife for an undisclosed amount.
Google helps pour $20m into Blue Bottle
True Ventures and Index Ventures have led the venture round for organic coffee company Blue Bottle Coffee.
Novartis prescribes $7m to Neurovance
Novartis Venture Fund has led the series A round for drug company Neurovance to develop their non-addictive ADHD combating drug.
Xange tips Currency Cloud with $1.9m
Xange Private Equity, a venture fund backed by France-based post office La Poste and other corporations, has invested in UK-based currency conversion and international payments service the Currency Cloud, in a £1.2m ($1.9m) deal. The Currency Cloud has raised £4.5m this year. Xange Private Equity, which is investing via its XAnge Capital 2 fund, is… Continue reading Xange tips Currency Cloud with $1.9m
Prism Skylabs captures $7.5m
Prism Skylabs and investors raise funds to monitor shoppers.
Raine Group leads venture round for two startups
Raine Group leads two US startups through late stage venture rounds as it oversees Japanese telecommunications giant Softbank’s takeover of Sprint Nextel.